Charles Schwab Investment Management Inc Gilead Sciences, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 8,015,530 shares of GILD stock, worth $869 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
8,015,530
Previous 8,002,779
0.16%
Holding current value
$869 Million
Previous $739 Million
21.5%
% of portfolio
0.17%
Previous 0.14%
Shares
31 transactions
Others Institutions Holding GILD
# of Institutions
2,285Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.7 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.45 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.92 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.81 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $136B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...